MOH
LONGINSIDER SELLMOLINA HEALTHCARE INC
Research: Finviz ↗·Perplexity ↗
🗄 Viewing archived Q1 2026 data — frozen, no longer refreshed.
News Summary
NegativeMolina beat Q2 adjusted EPS but faced significant headwinds: Medicaid membership declined to 4.9M, Medical Care Ratios deteriorated sharply (MCR up 180 bps YoY to 92.2%), and full-year Marketplace guidance was slashed by $1.50/share due to unfavorable acuity. Management signaled Medicaid margin pressures have reached a 'trough,' but the company is strategically retreating from ACA operations (scaling to 6 states) and absorbing a non-recurring $1.50/share Florida CMS contract drag in 2026.
Red flags
- •Medicaid MCR deteriorated 180 bps YoY to 92.7%; consolidated MCR at 92.2% signals profitability pressure
- •Premium revenue down 4% YoY; membership declined from 5.0M to 4.9M sequentially
- •Full-year Marketplace guidance cut by $1.50/share, swinging from gain to loss
- •Net income down 76% YoY despite EPS beat
- •Shareholder investigation into alleged nondisclosure of medical cost trend assumptions and 2025 guidance reliability
- •Florida CMS contract implementation dragging 2026 by $1.50/share
- •Strategic pullback from ACA business (6 states only) reflects competitive weakness and profitability challenges
- •Consensus analyst rating 'Hold' with 11 of 17 analysts neutral; Wells Fargo downgraded to Equal Weight with PT cut
Funds Buying (3)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | % of Fund | QoQ | Status |
|---|---|---|---|---|---|---|---|
| Maverick Capital | Lee Ainslie | 646K | +646K | $86M | 1.0% | — | NEW |
| Baupost Group | Seth Klarman | 634K | +9K | $84M | 1.7% | +1% | Existing |
| Point72 | Steve Cohen | 318K | +318K | $42M | <0.1% | — | NEW |
Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.
Portfolio Context
Where MOH ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.
position #18 of this fund's book
- 15HERBALIFE LTD$136M
- 16GDS HLDGS LTD$123M
- 17AMERICOLD REALTY TRUST INC$89M
- 18MOLINA HEALTHCARE INC$84M
- 19GRUPO AEROMEXICO SAB DE CV$68M
- 20NORWEGIAN CRUISE LINE HLDGS$68M
- 21VAXCYTE INC$46M
position #34 of this fund's book
- 31COCA COLA CO$98M
- 32PHILIP MORRIS INTL INC$94M
- 33MCDONALDS CORP$91M
- 34MOLINA HEALTHCARE INC$86M
- 35VAXCYTE INC$80M
- 36NOVO-NORDISK A S$76M
- 37WAVE LIFE SCIENCES LTD$74M
Values are quarter-end position sizes. Shown only for funds where MOH ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.
Insider Activity
Beneficial Ownership (13D/13G)
| Filer | Form | Shares | % of Class | Filed | Src |
|---|---|---|---|---|---|
| T. Rowe Price Associates, Inc. | SC 13G/A | 994K | 1.9% | 2026-02-17 | ↗ |
| Capital World Investors | SC 13G/A | 3.5M | 6.8% | 2026-02-13 | ↗ |
| AQR Capital Management, LLC | SC 13G/A | 410K | 0.8% | 2026-02-12 | ↗ |
| FMR LLC | SC 13G | 3.0M | 5.8% | 2026-02-05 | ↗ |
| BlackRock, Inc. | SC 13G/A | 3.5M | 6.9% | 2026-01-21 | ↗ |
SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.